NTLA |
Intellia Therapeutics, Inc. |
Mar 1, 2024 |
2 |
$0 |
4 |
Mar 5, 2024 |
EVP, Chief Financial Officer |
NTLA |
Intellia Therapeutics, Inc. |
Jan 3, 2024 |
1 |
-$158K |
4 |
Jan 5, 2024 |
EVP, Chief Financial Officer |
NTLA |
Intellia Therapeutics, Inc. |
Jan 1, 2024 |
2 |
$0 |
4 |
Jan 3, 2024 |
EVP, Chief Financial Officer |
NTLA |
Intellia Therapeutics, Inc. |
Mar 1, 2023 |
2 |
$0 |
4 |
Mar 3, 2023 |
EVP, Chief Financial Officer |
NTLA |
Intellia Therapeutics, Inc. |
Jan 4, 2023 |
1 |
-$90.3K |
4 |
Jan 6, 2023 |
EVP, Chief Financial Officer |
NTLA |
Intellia Therapeutics, Inc. |
Jan 1, 2023 |
2 |
$0 |
4 |
Jan 4, 2023 |
EVP, Chief Financial Officer |
NTLA |
Intellia Therapeutics, Inc. |
Mar 1, 2022 |
1 |
$0 |
4/A |
Mar 4, 2022 |
EVP, Chief Financial Officer |
NTLA |
Intellia Therapeutics, Inc. |
Jan 1, 2022 |
5 |
-$114K |
4 |
Mar 3, 2022 |
EVP, Chief Financial Officer |
NTLA |
Intellia Therapeutics, Inc. |
Sep 7, 2021 |
3 |
-$576K |
4 |
Sep 9, 2021 |
EVP, Chief Financial Officer |
NTLA |
Intellia Therapeutics, Inc. |
Aug 30, 2021 |
15 |
-$4.21M |
4 |
Sep 1, 2021 |
EVP, Chief Financial Officer |
NTLA |
Intellia Therapeutics, Inc. |
Aug 5, 2021 |
5 |
-$2.64M |
4 |
Aug 6, 2021 |
EVP, Chief Financial Officer |